You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 6, December 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Definition of the Hurler-Hunter Phenotypes

A Review of 50 Patients

JULES G. LEROY, MD; ALLEN C. CROCKER, MD

Am J Dis Child. 1966;112(6):518-530.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN RECENT years increasing attention has been paid to the biochemical handicap in mucopolysaccharide metabolism shown by the children with Hurler's disease or with other forms of the Hurler-Hunter syndrome. Many reports have described the clinical features of individual typical patients, usually when advanced in manifestation, as an illustration of the bodily handicaps which accompany the demonstrated abnormality in the tissue and urinary mucopolysaccharide levels. No articles, however, have been directed toward early diagnostic problems and eventual natural history of an inclusive series of children in each of the phenotypic categories. The biochemical classification of the various subdivisions of the Hurler-Hunter syndrome is still imperfect, and prognostication and genetic counselling must rest at present on accurate classification of the pediatric patient on clinical grounds. Some major patterns with consistent expression and significant incidence have emerged, though certain patients show the abnormal mucopolysaccharide excretion but have clinical manifestations beyond the current . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From The Children's Cancer Research Foundation, the departments of medicine and pathology, The Children's Hospital Medical Center, and the Department of Pediatrics and Pathology, Harvard Medical School, Boston. Dr. Leroy is currently Research Fellow in Medical Genetics, The Helen Hay Whitney Foundation.


Footnotes

Received for publication May 12, 1966.

Reprint requests to 35 Binney St, Boston 02115 (Dr. Crocker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.